Better stoma care using the Stoma App: does it help? A first randomized double-blind clinical trial on the effect of mobile healthcare on quality of life in stoma patients.

"Declarations DisclosuresSebastiaan van der Storm is the content developer of the app and Marlies Schijven is the owner of the app. Eshter Consten declares she is Proctor for Intuitive Surgical. Willem Bemelman declares that he has received scientific grants from VIFOR and has received speaker fees from Janssen, Tilotts, Takeda, and Galapagos. The app development and study was funded by the Dutch “Stomach Liver Intestine Foundation” (Grant No. ZP 19-09) and SIDN funds (Grant No. 191124). Mark Govaert, Jurriaan Tuynman, Steven Oosterling, Brechtje Grotenhuis, Anke Smits, Hendrik Marsman, Charles van Rossem, Eino van Duyn, Lindsey de Nes, Emiel Verdaasdonk, Tammo de Vries Reiling, and Wouter Vening have no conflicts of interest or financial ties to disclose. Disclosures Sebastiaan van der Storm is the content developer of the app and Marlies Schijven is the owner of the app. Eshter Consten declares she is Proctor for Intuitive Surgical. Willem Bemelman declares that he has received scientific grants from VIFOR and has received speaker fees from Janssen, Tilotts, Takeda, and Galapagos. The app development and study was funded by the Dutch “Stomach Liver Intestine Foundation” (Grant No. ZP 19-09) and SIDN funds (Grant No. 191124). Mark Govaert, Jurriaan Tuynman, Steven Oosterling, Brechtje Grotenhuis, Anke Smits, Hendrik Marsman, Charles van Rossem, Eino van Duyn, Lindsey de Nes, Emiel Verdaasdonk, Tammo de Vries Reiling, and Wouter Vening have no conflicts of interest or financial ties to disclose."

"Funding This work was funded by Dutch “Stomach Liver Intestine Foundation” (Grant No. ZP 19-09) and SIDN funds (Grant No. 191124)."

"The Stoma APPtimize trial is a double-blind multicenter randomized controlled trial that was conducted since March 2021 in two academic hospital centers and across twelve teaching hospitals in the Netherlands. Data collection for the short-term outcomes was completed in April 2023. The study was approved by the local medical ethics committee of Amsterdam UMC registration number NL75119.018.20). The study protocol has been published previously []. The study is reported according CONSORT-EHEALTH (Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and online TeleHealth) checklist []."